CoChat

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

This study images dopamine release in response to a neurochemically specific challenge with the psychostimulant drug methylphenidate. Changes in synaptic dopamine induced by methylphenidate were evaluated with positron emission tomography and [11 C]raclopride, a D 2 receptor radioligand that is sensitive to endogenous dopamine. Methylphenidate significantly decreased striatal [11 C]raclopride binding. The decrease was variable and was negatively correlated with age. Mood and anxiety at baseline, were also correlated with methylphenidate‐induced DA changes. This strategy provides a tool to investigate the responsiveness of the dopamine system in the normal and diseased human brain and to investigate the neurochemical correlates of behavior. © 1994 Wiley‐Liss, Inc.

Overview

Integrity signals

Registry

Crossref · 10.1002/syn.890160402

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 68 references

Research works printed but not linked: 9

  1. Davis K. L., 1991, Dopamine in schizophrenia: a review and reconceptualization. Am. J, Psychiatry, 148, 1474
  2. Ekman G., 1967, The measurement of subjective reactions, Forsvarsedicine, 33, 27
  3. Ferris R., 1972, A comparison of the capabilities of isomers of amphetamine, deoxyperadrol and methylphenidate to inhibit the uptake of catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol., 14, 47
  4. Innis R. B., 1993, SPECT imaging demonstrates loss of striatal dopamine transporters in parkinson's disease, J. Nucl. Med., 34, 31
  5. Joseph J. A., 1990, The striatum, a microcosm for the examination of age‐related alterations in the CNS: a selected review. Rev. Biolog. Res, Aging, 4, 181
  6. Kandel D. B., 1989, Cessation of illicit drug use in young adulthood. Arch. Gen, Psychiatry, 46, 109
  7. Logan J., 1993, The effects of changes in blood flow on the distribution volume of [11C]raclopride binding, J. Nucl. Med., 34, 200
  8. Raichle M. E., 1983, Brain blood flow measured with intravenous H2 15O, J. Nucl. Med., 24, 790
  9. Wong D. F., 1992, C‐11 WIN 35,428 imaging of the dopamine transporter site in living human brain, J. Nucl. Med., 33, 964

Cited by

Items 101–200 of 379

Metadata

Authors
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., Burr, G., Cooper, T., & Wolf, A. P.
Affiliations
  • State University of New York (US)
  • Brookhaven National Laboratory (US)
  • Zucker Hillside Hospital (US)
  • New York University (US)
  • Northport VA Medical Center (US)
Venue
Synapse
Publisher
Wiley
Published
1994-04
Volume
16
Issue
4
Pages
255-262
ISSN
  • 0887-4476 (ISSN-L)
  • 1098-2396
OpenAlex
W2006715508
Cited by
379
References
68
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 2 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 12
FWCI
4.66
Type
journal article
Language
en
Open access
closed
Locations
  • Synapse (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy
  • National Institutes of Health (5p01ns015638-15)
  • National Institute on Drug Abuse (NIDA 5RO1-DA06891, R01DA006891)
  • National Institute of Neurological Disorders and Stroke (NINDS NS15638)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
endogenous dopamine, dopamine release, [11C]raclopride, dopamine D2 receptor, striatal dopamine, psychostimulants, age-related changes, mood, anxiety
MeSH terms
Adult, Affect, Anxiety, Basal Ganglia, Binding, Competitive, Brain, Brain Chemistry, Cerebrovascular Circulation, Dopamine, Humans, Male, Methylphenidate, Middle Aged, Salicylamides, Synapses, Tomography, Emission-Computed, Neostriatum, Raclopride, Dopamine D2 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.